Amanote Research
Register
Sign In
Ligand Binding Pathways of Clozapine and Haloperidol in the Dopamine D2 and D3 Receptors
doi 10.1021/acs.jcim.5b00457.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
The Study of mRNA Expression of Dopamine Receptors D2 and D3 in Schizophrenic Patients
The Egyptian Journal of Biochemistry and Molecular Biology
Effects of (-)-Stepholidine on NMDA Receptors: Comparison With Haloperidol and Clozapine
Acta Pharmacologica Sinica
Medicine
Pharmacology
Corrigendum: Simultaneous Multiple MS Binding Assays Addressing D1 and D2 Dopamine Receptors
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Quantitative Autoradiographic Analysis of the Binding of Mosapramine to Dopamine D3-Receptors.
Folia Pharmacologica Japonica
Pharmacology
Binding of Pramipexole to Extrastriatal Dopamine D2/D3 Receptors in the Human Brain: A Positron Emission Tomography Study Using 11c-FLB 457
PLoS ONE
Multidisciplinary
Decreased Striatal Dopamine Receptor Binding in Primary Focal Dystonia: A D2 or D3 Defect?
Movement Disorders
Neurology
The Brain Gene Expression Profile of Dopamine D2/D3 Receptors and Associated Signaling Proteins Following Amphetamine Self-Administration
Neuroscience
Neuroscience
Structure of the Human Dopamine D3 Receptor in Complex With a D2/D3 Selective Antagonist
Science
Multidisciplinary
Philosophy of Science
History
Yawning and Hypothermia in Rats: Effects of Dopamine D3 and D2 Agonists and Antagonists
Psychopharmacology
Pharmacology